Molecular Partners AG (MOLN)
3.72
-0.16
(-4.12%)
USD |
NASDAQ |
Jun 10, 16:00
3.72
0.00 (0.00%)
After-Hours: 20:00
Molecular Partners EPS Diluted (Quarterly) : -0.4472 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.4472 |
| December 31, 2025 | -0.423 |
| September 30, 2025 | -0.3955 |
| June 30, 2025 | -0.6597 |
| March 31, 2025 | -0.5059 |
| December 31, 2024 | -0.3473 |
| September 30, 2024 | -0.5704 |
| June 30, 2024 | -0.5025 |
| March 31, 2024 | -0.3941 |
| December 31, 2023 | -0.6786 |
| September 30, 2023 | -0.3943 |
| June 30, 2023 | -0.5417 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.4906 |
| December 31, 2022 | -0.5016 |
| September 30, 2022 | -0.4238 |
| June 30, 2022 | -0.1441 |
| March 31, 2022 | 5.002 |
| December 31, 2021 | -0.6016 |
| September 30, 2021 | -0.4153 |
| June 30, 2021 | -0.6175 |
| March 31, 2021 | -0.6267 |
| March 31, 2016 | -0.2117 |
| December 31, 2015 | 0.0706 |
| September 30, 2015 | 0.2582 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Kuros Biosciences Ltd. | -- |
| BeOne Medicines Ltd. | 1.970 |
| AC Immune SA | -0.1914 |
| CRISPR Therapeutics AG | -1.280 |
| Idorsia Ltd. | -0.3918 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.77M |
| Total Expenses (Quarterly) | 16.77M |
| Enterprise Value | 51.68M |
| Earnings Yield | -51.76% |
| Normalized Earnings Yield | -50.12 |